Acute Coronary Syndrome (ACS) represents a spectrum of conditions associated with acute myocardial ischemia. The management of ACS has evolved significantly over the years, with advancements in diagnostic tools, therapeutic modalities, and patient care strategies. This article aims to highlight the most recent advancements and best practices in ACS management.
High-sensitivity cardiac troponin assays have revolutionized the early detection of myocardial injury, allowing for prompt initiation of treatment. Novel imaging techniques, such as coronary computed tomography angiography (CCTA), provide non-invasive visualization of coronary anatomy and plaque characteristics, enhancing diagnostic accuracy.
Contemporary ACS management emphasizes early invasive strategies. Percutaneous coronary intervention (PCI) remains the cornerstone of revascularization, with drug-eluting stents showing superior outcomes. The use of novel antiplatelet agents, such as ticagrelor and prasugrel, has improved the efficacy of dual antiplatelet therapy. Additionally, the emergence of non-vitamin K antagonist oral anticoagulants (NOACs) provides a safer alternative to traditional anticoagulants.
High-quality care for ACS patients extends beyond acute management. Comprehensive discharge planning, including medication review and patient education, is crucial to prevent recurrent events. Multidisciplinary cardiac rehabilitation programs have demonstrated improved patient outcomes, emphasizing the importance of lifestyle modification and secondary prevention measures.
Emerging fields, such as genomics and precision medicine, hold promise for individualized ACS management. Moreover, artificial intelligence and machine learning tools are being explored to predict ACS events and guide therapeutic decisions.
ACS management has witnessed remarkable advancements, from diagnostic modalities to therapeutic interventions and patient care strategies. Continued research and innovation are crucial to further enhance patient outcomes. As healthcare professionals, we must stay abreast of these advancements to deliver the highest quality of care to our patients.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation